Nextnib 50mg Tablet is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient, **Nintedanib**, is a tyrosine kinase inhibitor that works by blocking specific enzymes (tyrosine kinases) that are involved in the growth and proliferation of cancer cells. By inhibiting these pathways, Nextnib helps to slow down or stop the progression of the disease.
This medication is primarily indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF), a chronic lung disease characterized by progressive scarring of lung tissue, and certain types of non-small cell lung cancer (NSCLC) that have specific genetic mutations. It is also used in combination with other treatments for certain other cancers.
The typical dosage and administration of Nextnib 50mg Tablet should be strictly followed as prescribed by a healthcare professional. It is usually taken orally, with or without food. Common side effects may include diarrhea, nausea, vomiting, abdominal pain, elevated liver enzymes, and fatigue. It is crucial to report any persistent or severe side effects to your doctor immediately.
Nextnib 50mg Tablet should be stored at room temperature, away from moisture and heat. Keep out of reach of children. Always consult your doctor or pharmacist for personalized medical advice and before starting or stopping any medication.
